HIPRA

Amer, Spain Founded: 1996 • Age: 30 yrs
Vaccines and diagnostic kits for animal diseases are developed.

About HIPRA

HIPRA is a Healthcare company based in Amer (Spain) founded in 1996. Vaccines and diagnostic kits for animal diseases are developed. The company has 22 employees. HIPRA has completed 1 acquisition, including GoodGut. Its website hipra.com draws about 52 thousand monthly visits. Its Indian entity Hipra India Private Limited reported revenue of ₹38.24 Cr. Its focus areas include HealthTech, Veterinary HealthTech, Biopharmaceuticals and Companion Animals.

Company details

HIPRA was established in 1996 in Amer, Spain, within the animal health sector. Vaccines are produced for conditions such as viral nervous necrosis, bursal disease, and respiratory syncytial virus. Diagnostic kits are offered for detection and quantification of pathogens including mycoplasma hyopneumoniae and Leishmania donovani infantum. Operations focus on veterinary applications, with services extending to various animal species across international markets.

  • Headquarters Amer, Spain
  • Employees 22
  • Sectors
    Healthcare
  • Website category Pets and Animals · Pet Food and Supplies
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website hipra.com/en
  • Social LinkedIn YouTube
  • Legal Name Hipra India Private Limited
  • Date of Incorporation 14 Feb, 2012
  • Jurisdiction Pune, Maharashtra, India
Key Metrics
  • Indian entity revenue
    ₹38.24 Cr

    FY 2025 · +40% YoY

  • Indian entity net profit
    ₹21.2 Lakh

    FY 2025 · 1% margin

  • Indian entity EBITDA
    ₹22.6 Lakh

    FY 2025 · 1% margin

  • Latest Funding Round
    $2.35M (USD), Grant

    Dec 2021

  • Investors
  • Employee Count
    22
  • Investments & Acquisitions

Apps and channels of HIPRA

its YouTube channel HIPRA has 24 subscribers and 16 videos.

HIPRA
YouTube 24 subscribers 16 videos Science & Technology
Open channel

Videos from HIPRA

The most watched videos on HIPRA's YouTube channel, HIPRA (24 subscribers). Click a video to play it here.

Building Immunity for a Healthier World
4.8K views
Inauguration of the HIPRA Campus
166 views
Life at HIPRA – Marta Figa, Quality Director, Animal Health
144 views
Life at HIPRA - Gabriel Álvarez Álvarez, Regional Manager of Americas
142 views

More on HIPRA.

Funding Insights of HIPRA

  • Total Rounds 1
  • Last Round Grant — $2.35M
  • First Round $2.35M

    (Dec 2021)

  • Investors Count 1

All 1 funding rounds of HIPRA with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Dec 2021$2.35MGrant––
Valuation history

1 investors in total: 1 institutional.

Investors in HIPRA

HIPRA has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
Premium access

Investor details for HIPRA

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Hipra India Private Limited (HIPRA)

Hipra India Private Limited is the primary company behind HIPRA. The board of Hipra India Private Limited currently have 7 directors; the longest-serving is Maria Del Mar Nogareda Estivill, appointed in 2012. 8 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Maria Del Mar Nogareda Estivill
DIN 05151743
Director14 Feb 201214 yrs 8 moHipra India Private Limited
David Nogareda Estivill
DIN 05151771
Director14 Feb 201214 yrs 8 moHipra India Private Limited
Carlos Montanes Estupina
DIN 05151764
Director14 Feb 201214 yrs 8 moHipra India Private Limited
Elia Torroella Busquets
DIN 06743910
Director25 Nov 201312 yrs 11 moHipra India Private Limited
Jameer Daulat Patel
DIN 03630325
Director24 Apr 201412 yrs 6 moHipra India Private Limited
David Caballero Tomas
DIN 11176535
Director07 Jul 20251 yr 3 moHipra India Private Limited
Peter Cyriel A Saey
DIN 11176549
Director07 Jul 20251 yr 3 moHipra India Private Limited

People of HIPRA

145 people are tracked at HIPRA (16 in leadership, 129 in team); the tracked headcount is 22.

NameRoleGroup
Joan Tarradas
Managing DirectorLeadership
Managing Director Animal Health DivisionLeadership
Anna Corcoll Rovira
Manufacturing Associate DirectorLeadership
Carles Fabrega
Managing Director Human Health DivisionLeadership
PresidentLeadership
Johannes Heinz
Head Of SalesLeadership
Sergi Bosch Serrano
Digital Health DirectorLeadership
Mireia Torres
Regulatory Affairs DirectorLeadership
Josep Ferrés Corominas
Quality Compliance & Contract Manufacturing Executive DirectorLeadership
Arnau Nogareda
Director GeneralLeadership
Marta Figa Bosch
Strategic Projects Director, HHLeadership
Global Business Director Hipra AHLeadership
Jordi Colomer
Manufacturing Director (animal Health Division)Leadership
Laura Ferrer Soler
Director R&d Human Health And Companion AnimalLeadership
Ricard March
Ceyc, Preclinical & Clinical Development DirectorLeadership
Xavier de Paz
Marketing DirectorLeadership
Kristy Naldo
Technical Services Asia & OceaniaTeam
Martijn Seelie
Ruminants Franchise Manager at HIPRA HeadquartersTeam
Yenny Parra
Sales Representative at HIPRA ColombiaTeam
Gregori Bech-Sàbat
Researcher In Pre-clinical DevelopmentTeam

125 more people are available in the full profile.

Premium access

Complete people profiles for HIPRA

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of HIPRA

Figures of Hipra India Private Limited, the primary company behind HIPRA, for FY 2025. Revenue was ₹38.24 Cr (+40% year on year). Net profit was ₹21.2 Lakh (1% margin). EBITDA was ₹22.6 Lakh (1% margin). Revenue has grown at a compounded annual rate of +42% over three years and +58% over five years.

  • ₹38.24 CrRevenue · FY 2025 · +40% YoY
  • ₹21.2 LakhNet profit · 1% margin
  • ₹22.6 LakhEBITDA · 1% margin
  • ₹29.36 CrPaid-up capital
  • 22Employees (provident fund records)
  • +42%Revenue CAGR, 3 years
  • +58%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Hipra India Private Limited are on its company page.

Premium access

Detailed financial statements for HIPRA

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by HIPRA

HIPRA has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include GoodGut.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Diagnosis and treatment of digestive diseases based on intestinal microbiota analysis
goodgut.euGirona, Spain2014Sep 2021••••
Premium access

Complete acquisition details for HIPRA

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of HIPRA

3 dated milestones of HIPRA across 25 years, from founding to its latest funding, stage changes and deals.

  1. Founded HIPRA is founded.
  2. Acquisition Acquires GoodGut.
  3. Funding First funding round of $2.3M.

Web traffic of HIPRA

The website of HIPRA (hipra.com) receives about 52.5K visits a month and ranks #601,506 among all websites worldwide, #4,925 in Pet Food and Supplies.

  • Monthly visits
    52.5K

    ▲ 2.2% vs previous month

  • Unique visitors
    21.1K

    per month

  • Global rank
    #601,506

    among all websites

  • Category rank
    #4,925

    Pets and Animals · Pet Food and Supplies

Similar websites

Websites whose visitors overlap most with HIPRA. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
syva.es
100%
#3,684,528View details
daphorst.nl
daphorst.nl
83%
–
elanco.com
82%
592.4K#115,154View details
fatro.it
82%
680.7K#9,484,064View details
candioli.it
candioli.it
82%
#8,384,690–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
••••••••••••••••.com••%•.•M#•••••–
Premium access

All 25 similar websites and full traffic analytics for HIPRA

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 25 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Hipra

Premium access

Complete news archive for HIPRA

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about HIPRA

HIPRA was founded in 1996 and raised its 1st funding round 25 years after it was founded.

HIPRA is headquartered in Amer, Spain. It is registered at Amer, Cataluna, Spain.

HIPRA has 22 employees.

The primary company behind HIPRA, Hipra India Private Limited, reported revenue of ₹38.24 Cr for FY 2025, up 40% year on year.

HIPRA was established in 1996 in Amer, Spain, within the animal health sector. Vaccines are produced for conditions such as viral nervous necrosis, bursal disease, and respiratory syncytial virus. Diagnostic kits are offered for detection and quantification of pathogens including mycoplasma hyopneumoniae and Leishmania donovani infantum. Operations focus on veterinary applications, with services extending to various animal species across international markets.

HIPRA has made 1 acquisition, including GoodGut.

HIPRA has 1 investor. Key investors include European Union.

HIPRA operates through Hipra India Private Limited.

The legal entities of HIPRA currently have 8 directors, including Elia Torroella Busquets, Jameer Daulat Patel, Maria Del Mar Nogareda Estivill and others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available